Literature DB >> 32928002

Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study.

Josep Darbà1, Alicia Marsà2.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is the most common form of dementia. Its neurodegenerative nature and the lack of a curative treatment result in a substantial burden for healthcare systems and society. This study aimed to analyze the hospital incidence and mortality of AD in Spain and to evaluate patients' use of healthcare resources and direct medical costs.
METHODS: Admission records of patients with AD treated in hospitals in Spain between 2011 and 2016 were selected from a Spanish hospital discharge database.
RESULTS: Records of 7,894 patients with diagnosed AD were analyzed. Hospital incidence was 3.7 per 10,000 persons over the study period, 2.9 and 4.4 for males and females, respectively. In-hospital mortality was 9.5%; both hospital incidence and in-hospital mortality increased over the study period. Mortality was principally associated with acute respiratory failure and other diseases of the respiratory system and heart failure. Annual medical costs of specialized care increased slightly during the study period, with a mean annual cost per patient of €4,969.
CONCLUSIONS: AD is responsible for an increasing proportion of hospitalizations in Spain and raising medical costs, which highlights the importance of early detection and optimized care.

Entities:  

Keywords:  Alzheimer’s disease; Spain; incidence; medical costs; mortality

Mesh:

Year:  2020        PMID: 32928002     DOI: 10.1080/14737167.2020.1820328

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  2 in total

1.  Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong.

Authors:  Hiu Yi Wong; Huan Zhong; Mingqian Zhong; Xiaopu Zhou; Phillip Y C Chan; Timothy C Y Kwok; Kin Mok; John Hardy; Fanny C F Ip; Amy K Y Fu; Nancy Y Ip
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 2.  The Humanistic and Economic Burden of Alzheimer's Disease.

Authors:  Amir Abbas Tahami Monfared; Michael J Byrnes; Leigh Ann White; Quanwu Zhang
Journal:  Neurol Ther       Date:  2022-02-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.